ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Behcet’s syndrome"

  • Abstract Number: 2370 • 2012 ACR/ARHP Annual Meeting

    A Genome-Wide DNA Methylation Study Identifies Significant Epigenetic Changes Across the Genome and in Multiple HLA Loci in Behcet’s Disease

    Haner Direskeneli1, Patrick S. Coit2, Filiz Ture-Ozdemir1, Fatma Alibaz-Oner1, Guher Saruhan-Direskeneli3, Matlock A. Jeffries4 and Amr H. Sawalha2, 1Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 2Division of Rheumatology, University of Michigan, Ann Arbor, MI, 3Department of Physiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 4Medicine, University of Oklahoma and Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Behcet’s disease (BD) is a systemic vasculitis of poorly understood etiology. Herein, we study the DNA methylome in BD for the first time and…
  • Abstract Number: 2371 • 2012 ACR/ARHP Annual Meeting

    The Unmet Need in Behcet’s Disease: Most Patients Are Not in Complete Remission in the Long-Term Follow-up

    Fatma Alibaz-Oner1, Gonca Mumcu2, Gülsen Ozen3, Zeynep Kubilay4, Meryem Can1, Sibel Yýlmaz Oner1, Tülin Ergun5 and Haner Direskeneli1, 1Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 2Department of Health Management, Marmara University, Faculty of Health Sciences, Istanbul, Turkey, 3Rheumatology, Marmara University School of Medicine., Istanbul, Turkey, 4Internal Medicine, Marmara University, School of Medicine, Istanbul, Turkey, 5Dermatology, Marmara University School of Medicine, Istanbul, Turkey

    Background/Purpose: The nature of Behcet’s disease (BD) as a multi-systemic disorder with a remitting-relapsing course is unsufficiently explored. As complete remission should be aimed in…
  • Abstract Number: 2372 • 2012 ACR/ARHP Annual Meeting

    Efficacy of Quantitative Analysis of Brainstem Atrophy On Magnetic Resonance Imaging for Diagnosis of Chronic Progressive Neuro-Behçet’s Disease

    Hirotoshi Kikuchi1, Maki Takayama2, Yoshitaka Kimura2, Kurumi Asako2, Hajime Kono2, Yasuo Ono1 and Shunsei Hirohata3, 1Department of Microbiology and Immunology, Teikyo University Shool of Medicine, Tokyo, Japan, 2Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 3Int Med/Rheumatol & Infec Dis, Kitasato University School of Medicine, Sagamihara, Japan

    Background/Purpose : CNS involvement in Behçet's disease, usually called neuro-Behçet's disease (NB), can be classified into acute NB (ANB) and chronic progressive NB (CPNB) based…
  • Abstract Number: 2373 • 2012 ACR/ARHP Annual Meeting

    The Clinical Course of the Acute Deep Vein Thrombosis of the Legs in Behçet’s Syndrome

    Yesim Ozguler1, Melike Melikoglu2, Firat Cetinkaya3, Serdal Ugurlu4, Emire Seyahi5, Koray Tascilar6 and Hasan Yazici7, 1Cerrahpasa Medical Faculty, Istanbul University, Cerrahpasa Medical School, Rheumatology, Istanbul, Turkey, 2Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, 3Radiology, Colormed Radiology Center, Istanbul, Turkey, 4Rheumatology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey, 5Rheumatology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey, 6University of Istanbul, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, 7Istanbul University, Cerrahpasa Medical School, Rheumatology, Istanbul, Turkey

    Background/Purpose: 15-50% of patients with Behçet’s syndrome have vascular involvement (BS). Deep vein thrombosis is the most common form with lower extremity deep vein thrombosis…
  • Abstract Number: 2374 • 2012 ACR/ARHP Annual Meeting

    Characteristics, Treatment and Outcome of Gastrointestinal Involvement in Behcet’s Syndrome: Experience in A Dedicated Center

    Ibrahim Hatemi1, Gulen Hatemi2, Yusuf Erzin1, Aykut Ferhat Celik1 and Hasan Yazici3, 1Istanbul University, Cerrahpasa Medical School, Istanbul University, Cerrahpasa Medical School, Gastroenterology, Istanbul, Turkey, 2Istanbul University, Cerrahpasa Medical Faculty, Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, 3Istanbul University, Cerrahpasa Medical School, Istanbul University, Cerrahpasa Medical School, Rheumatology, Istanbul, Turkey

    Background/Purpose: Gastrointestinal involvement can be a severe complication resulting in perforation and massive bleeding. Controlled data regarding treatment is lacking and long term prognosis is…
  • Abstract Number: 2376 • 2012 ACR/ARHP Annual Meeting

    Behcet’s Disease: Combination of Pulse Cyclophosphamide, Azathioprine, and Prednisolone for the Treatment of Retinal Vasculitis; Longitudinal Study On 10 Years

    Fereydoun Davatchi1, Farhad Shahram2, Bahar Sadeghi Abdollahi2, Hormoz Shams2, Abdolhadi Nadji2, Massoomeh Akhlaghi2, Tahereh Faezi2 and Farimah Ashofteh2, 1Rheumatology Research Ctr and Department of Rheumatology, Shariati Hospital-Tehran Univ, Tehran, Iran, 2Rheumatology, Behcet's Unit, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Background/Purpose: Ocular lesions of Behcet’s Disease (BD), need aggressive treatment to prevent severe loss of vision or blindness. Cytotoxic drugs are the main therapeutic agents…
  • Abstract Number: 1005 • 2012 ACR/ARHP Annual Meeting

    The Identification of Pathway Markers in Behcet’s Disease Using Genomewide Association Data From Two Different Populations

    Burcu Bakir-Gungor1, Elaine Remmers2, Daniel L. Kastner2, Akira Meguro3, Nobuhisa Mizuki4, Ahmet Gul5 and Osman Ugur Sezerman6, 1Department of Genetics and Bioinformatics, Faculty of Arts and Sciences, Bahcesehir University, Istanbul, Turkey, 2Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 3Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 4Yokohama City University Graduate School of Medicine, Yokohama, Japan, 5Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 6Biological Sciences and Bioengineering, Faculty of Engineering and Natural Sciences, Sabancı University, Istanbul, Turkey

    Background/Purpose: Behcet's disease (BD) is a multi-system inflammatory disease, characterized by recurrent exacerbations affecting several organs including orogenital mucosa, eyes and skin. Two recent genome-wide…
  • Abstract Number: 858 • 2012 ACR/ARHP Annual Meeting

    Dense Genotyping, Imputation, and Regression Analysis Identifies Multiple Independent Genetic Susceptibility Loci within the HLA Region in Behcet’s Disease

    Travis Hughes1, Adam Adler2, Patrick S. Coit1, Vuslat Yilmaz3, Kenan Aksu4, Nursen Duzgun5, Gokhan Keser4, Ayse Cefle6, Ayten Yazici6, Andac Ergen7, Erkan Alpsoy8, Carlo Salvarani9, Bruno Casali10, Ina Koetter11, Javier Gutierrez-Achury12, Cisca Wijmenga12, Haner Direskeneli13, Guher Saruhan-Direskeneli14 and Amr H. Sawalha1, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Istanbul University, Istanbul Faculty of Medicine, Department of Physiology, Istanbul, Turkey, 4Dept. of Internal Medicine, Division of Rheumatology, Ege University, Izmir, Turkey, 5Ankara University, Ankara, Turkey, 6Department of Rheumatology, Kocaeli University, Kocaeli, Turkey, 7Okmeydaný Research and Education Hospital, Istanbul, Turkey, 8Department of Dermatology, Akdeniz University, Antalya, Turkey, 9Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 10Molecular Biology Laboratory, Arcispedale S. Maria Nuova,, Reggio Emilia, Italy, 11Robert Bosch Krankenhaus, Stuttgart, Germany, 12Department of Genetics, University Medical Hospital Groningen, University of Groningen, Groningen, Netherlands, 13Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 14Department of Physiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: The genetic association between HLA-B51 and Behcet’s disease is well established. However, localizing this genetic effect and exploring additional susceptibility loci within the HLA…
  • Abstract Number: 203 • 2012 ACR/ARHP Annual Meeting

    Clinical Course Factors Associated with Outcome of Monoarthritis : A Retrospective Study of 173 Cases

    Hyemin Jeong1, Eun-Jung Park1, Jiwon Hwang1, Ji Young Chai2, Joong Kyong Ahn3, Eun-Mi Koh4 and Hoon-Suk Cha1, 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Division of Rheumatology, Jesang Hospital, Seongnam-si Gyeonggi-do, South Korea, 3Department of Medicine, Kangbuk Samsung hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 4Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Seoul, South Korea

    Background/Purpose: To evaluate the clinical features and outcomes in patients with monoarthritis and to investigate predictive factors associated with the clinical course in terms of…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology